What Ovesco Endoscopy AG does

Ovesco Endoscopy AG is a privately held German medical device company (Aktiengesellschaft) headquartered in Tübingen that develops, manufactures, and markets minimally invasive endoscopic instruments and systems for the treatment of gastrointestinal diseases. The company's core platform is the OTSC® (Over-the-Scope Clip) system, an innovative endoscopic clipping system for gastrointestinal hemorrhage treatment and digestive organ wall closure. From this foundation, Ovesco has built a comprehensive product portfolio spanning clipping (OTSC® variants, OTSC® Proctology, mini OTSC®), full-thickness resection (FTRD®, FTRD®neo), advanced resection techniques (RESECT+ with LiftUp®, AWC®, AWC®duo, Coag Dissector, AqaNife®), diagnostic sensor capsules (HemoPill® acute), lumen reduction (BARS®), stent fixation (stentFIX), clip removal (remOVE), and accessory caps (ScopeCaps, OTSG Xcavator®).

The company operates a direct enterprise field sales model, with regional operations in Germany, USA, France, and India, and its products are used in patients in over 70 countries. Revenue is generated through hardware sales of proprietary medical devices and systems to hospitals, university medical centers, and specialized endoscopy centers, with comprehensive support from training to intervention reflecting a consultative sales approach. Pricing is not publicly disclosed. The company has been recognized as a Financial Times Long Term Growth Champion in 2026 for the second consecutive year, employs a formal management and supervisory board structure, and has received workplace culture awards (Kununu 2025, Leading Employers 2026). No AI/ML capabilities, public funding rounds, or disclosed revenue figures are noted in the available data.

Name

Ovesco Endoscopy AG

Legal name

Ovesco Endoscopy AG

Website

https://ovesco.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

Ovesco Endoscopy AG is a privately held German medical device company that develops, manufactures, and markets minimally invasive endoscopic clipping, resection, and diagnostic systems for hospitals and gastroenterologists treating gastrointestinal diseases, distributing through direct sales in over 70 countries.

Ownership category

akta.pro rank

Product category

Gastrointestinal Endoscopy Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

akta.pro secondary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

Keywords

• Endoscopic clipping systems
• Gastrointestinal medical devices
• Flexible endoscopy instruments
• Endoluminal surgery devices
• Full-thickness resection devices

Headquarters

HQ city

Los Gatos

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Development, manufacturing, and marketing of endoscopic instruments and systems for gastrointestinal disease treatment. Revenue is generated through the sale of proprietary medical devices and systems including clipping systems, resection devices, diagnostic capsules, and related accessories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Ovesco Endoscopy AG develops, manufactures, and markets endoscopic medical devices and systems for the treatment of gastrointestinal diseases. Its core offering is the OTSC® over-the-scope clipping system and related platforms (FTRD®, HemoPill®, BARS®, remOVE, RESECT+, stentFIX, ScopeCaps) used by hospitals and gastroenterologists for hemostasis, tissue closure, full-thickness resection, stent fixation, and diagnostic detection of bleeding in the GI tract.

Product overview

Ovesco Endoscopy AG offers a comprehensive portfolio of endoscopic medical devices for gastrointestinal procedures. The core platform is the OTSC® clipping system for hemostasis and tissue closure, which has spawned multiple specialized variants including the OTSC®neo (performance evolution), mini OTSC® (compact applications), and OTSC® Proctology (anorectal fistulas). The company expanded into resection with the FTRD® and FTRD®neo full-thickness resection systems, and the RESECT+ line featuring LiftUp® injection, AWC®/AWC®duo working channels, and various resection tools. Supporting products include stentFIX for fixation, BARS® for lumen reduction, remOVE for clip removal, HemoPill® diagnostic capsules with optical sensors, and ScopeCaps accessories. The company provides complete procedural solutions from training to intervention, serving patients in over 70 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• OTSC®: Core product platform for the treatment of gastrointestinal hemorrhage and endoscopic digestive organ wall closure
• FTRD®
• FTRD®neo
• RESECT+
• stentFIX
• BARS®
• remOVE System
• HemoPill®
• ScopeCaps
• OTSC® Proctology
• OTSC®neo

Products and services

• OTSC® System Flagship over-the-scope endoscopic clipping system for treatment of gastrointestinal hemorrhage and endoscopic digestive organ wall closure; serves as the foundational platform enabling hemostasis, fistula closure, stent fixation, and tissue approximation.
• OTSCneo System Next generation evolution of the OTSC system with improved clip application performance for gastrointestinal procedures.
• mini OTSC® System Compact version of the OTSC system for use in small lumen or difficult-to-access lesions, applying the OTSC technique in a smaller form factor.
• OTSC® Proctology Clipping system for sphincter-preserving closure of anorectal fistulas, including dedicated proctology set, anchor, and fistula brush.
• FTRD® System Full-thickness resection device that removes non-lifting and complex GI lesions that previously required surgery, achieving high R0 resection rates.
• FTRDneo System Peak performance version of the full-thickness resection system with enhanced clip application for lesions in the gastrointestinal tract.
• stentFIX System Innovative solution for stent fixation in the digestive tract that prevents stent migration.
• BARS® Lumen reduction system based on the OTSC platform, developed for enlarged anastomoses following RYGB procedures, enabling simultaneous use of three application aids with conventional single-channel endoscopes.
• remOVE System Endoscopic clip removal system for fragmentation of OTSC and FTRD clips, including DC Impulse, DC Cutter, and SecureCap components.
• RESECT+ Endoscopic resection product line including LiftUp (thermo-reversible injection agent), AWC (additional working channel for ESD), RampCap, Traction Snare, Coag Dissector, and AqaNife for safe and efficient endoscopic resection.
• AWCduo Additional working channel with flexible spacer cap providing 2-in-1 functionality for dynamic resection and various endoscopic procedures including ESD.
• HemoPill® Diagnostic sensor capsule system including HemoPill acute for immediate detection of acute bleeding in the esophagus, stomach, and small intestine using optical sensor technology.
• ScopeCaps Cap accessories for endoscopes including SecureCap, ArgoCap (for APC procedures), BougieCap (for bougienage with visual control), FBR Set (foreign body retrieval), and OTSG Xcavator (large capacity grasping).
• OTSG Xcavator® Endoscopic grasping device with maximum grasping volume for removal of necrotic tissue, blood clots, food boluses, and foreign bodies from the GI tract.

Quantifiable outcome

• 84% risk reduction in early recurrent bleeding (OR 0.16; p = 0.017) vs endoscopic therapy in colonic diverticular hemorrhage
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• German-American Institute in TübingenminorOthersOvesco Endoscopy is now a member of the German-American Institute in Tübingen, indicating alignment with cross-border business and academic collaboration initiatives in the region.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cook Medical: Cook Medical has a broad GI endoscopy product line including clips, stents, and retrieval devices, competing with multiple Ovesco product families (OTSC, stentFIX, FBR Set). Cook is a privately held broad incumbent with global reach, similar to Ovesco's distributor-supported model in many markets.
• Medtronic: Medtronic's GI Solutions business offers endoscopic hemostasis, resection, and bariatric products that overlap with Ovesco's OTSC and BARS franchises. While Medtronic is a diversified medical device giant, its GI segment is a relevant comparable for therapeutic endoscopy sales motion and hospital contracting dynamics.
• Fujifilm Healthcare (incl. former Pentax Medical): Fujifilm (which acquired Pentax Medical's endoscopy business) is a major endoscopy systems provider with an expanding therapeutic accessories portfolio. It competes with Ovesco's clipping and resection systems while also supplying the scopes and processors used in conjunction with Ovesco devices.
• Olympus Corporation: Olympus is the dominant player in flexible endoscopy hardware and also sells therapeutic accessories including hemostasis clips and resection devices. While Olympus's core business is endoscopes themselves, its therapeutic accessory portfolio overlaps directly with Ovesco's OTSC and FTRD systems, and its installed base gives it a structural channel advantage.
• Boston Scientific: Boston Scientific is one of the largest diversified medical device companies with a substantial endoscopy franchise (hemostasis clips, stents, resection tools). It competes with Ovesco's OTSC and FTRD lines in therapeutic endoscopy but operates across many other device categories as well, making it a broad incumbent rather than a direct niche specialist.

Emerging players

• Micro-Tech Endoscopy: Micro-Tech Endoscopy is a privately held Chinese-based manufacturer of GI endoscopy accessories including biopsy forceps, hemoclips, and snares. As a cost-competitive emerging player, it competes with Ovesco in select commoditized segments and represents a margin/pricing threat to established Western OEMs.

Direct peers

• Apollo Endosurgery: Apollo Endosurgery is a smaller specialist focused on endoscopic bariatric and gastrointestinal procedures, including endoscopic suturing and weight-loss interventions. Its overlap with Ovesco's BARS (post-RYGB lumen reduction) and overlap in the advanced GI endoscopy procedure market make it a directly comparable niche specialist.
• CONMED Corporation: CONMED's GI/endoscopy business sells hemostasis, resection, and closure devices to gastroenterologists and hospitals. Its product mix and target customer base closely align with Ovesco's OTSC, FTRD, and RESECT+ lines, making it a strong direct peer for therapeutic endoscopy consumables.
• STERIS (US Endoscopy): STERIS owns US Endoscopy, which develops and sells therapeutic and diagnostic accessories for GI endoscopy including hemostasis clips and retrieval devices. US Endoscopy directly competes with Ovesco's OTSC and ScopeCaps portfolios, making it one of the closest direct peers in the US market.

Others

• Erbe Elektromedizin: Erbe is a German-based specialist in electrosurgery and endoscopic instrumentation, including devices used in ESD/EMR procedures that overlap with Ovesco's RESECT+ line (Coag Dissector, AqaNife). It is a complementary/enabling technology provider rather than a direct clip-system competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/ovesco
• Facebookfacebook.com/ovescoendoscopy
• LinkedInlinkedin.com/company/ovesco-endoscopy

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ovesco Endoscopy AG